Delivery Order SPE2DR25D3004-SPE2DR26FXVM5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,073.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL) on December 30, 2025, with an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price contract is classified as a non-set-aside delivery order with performance to be completed by October 9, 2025, at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,490 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating AmerisourceBergen competed against other...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a $11,536.50 delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Gel-One 30 mg/3 mL syringes. This is a firm fixed-price contract with an ultimate completion date of February 13, 2026, and represents a non-competitive set-aside award. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. As a child entity of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency awarded a $3,845.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 12, 2025, with an ultimate completion date of January 6, 2026. The non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's comprehensive pharmaceutical supply agreement with the DLA. This award falls...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes valued at $7,691.00 with a firm fixed price structure. This non-competitive delivery order, issued on November 12, 2025, is scheduled for completion by December 4, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXVM5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,538.20 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on January 27, 2026, with an ultimate completion date of February 18, 2026. This firm fixed-price delivery order, which was not set-aside, represents a continuation of pharmaceutical supply services under the company's broader contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a wide range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The competitively awarded structure demonstrates AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains for military treatment facilities and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/26/26 |